Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-058026

Chief Executive Officer sold 81,500 shares at an average $14.39 ($1,172,705)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2018-11-09 Sale −76,200 $14.35 $1,093,470 1,727,755 D: show line 1 in the form
Anzalone Christopher Richard Chief Executive Officer 2018-11-09 Sale −5,300 $14.95 $79,235 1,722,455 D: show line 2 in the form
Open-market sales · 81,500 sh · avg $14.39 · $1,172,705
Loading xslF345X03/doc4.xml…